Login
Evidence Feed
About
Diagnostics
New
Top genes
FAQ
Contact us
^
Login
Contact us
to learn more about
our Premium Content: News alerts, weekly reports and conference planners
DRUG:
RMC-7977
i
Other names:
RMC-7977
Contact us
to learn more about our Premium Content:
News alerts, weekly reports and conference planners
Associations
(2)
News
Trials
Company:
Revolution Medicines
Drug class:
RAS inhibitor
Related drugs:
‹
RMC-6236 (3)
JZP815 (2)
IODVA1 (1)
NEO100 (1)
DO-2 (0)
GI-4000 (0)
antroquinonol (0)
KY1022 (0)
PRLX 93936 (0)
RMC-6236 (3)
JZP815 (2)
IODVA1 (1)
NEO100 (1)
DO-2 (0)
GI-4000 (0)
antroquinonol (0)
KY1022 (0)
PRLX 93936 (0)
›
Associations
(2)
News
Trials
VERI cancer hierarchy
Reset Filters
FLT3 mutation
Acute Myelogenous Leukemia
FLT3 mutation
Acute Myelogenous Leukemia
gilteritinib + RMC-7977
Sensitive: D – Preclinical
gilteritinib + RMC-7977
Sensitive
:
D
gilteritinib + RMC-7977
Sensitive: D – Preclinical
gilteritinib + RMC-7977
Sensitive
:
D
FLT3 mutation + NRAS mutation
Acute Myelogenous Leukemia
FLT3 mutation + NRAS mutation
Acute Myelogenous Leukemia
gilteritinib + RMC-7977
Sensitive: D – Preclinical
gilteritinib + RMC-7977
Sensitive
:
D
gilteritinib + RMC-7977
Sensitive: D – Preclinical
gilteritinib + RMC-7977
Sensitive
:
D
^
^
Full access to predictive biomarker details and heatmap analytics are available with a VERI Account.
Sign up for FREE
Already have an account?
Login
Full access to predictive biomarker details and heatmap analytics are available with a VERI Account.
Sign up for FREE
Already have an account?
Login